Recent Advances on Drugs and Vaccines for COVID-19

The current situation of Coronavirus Disease 2019 (COVID-19) worldwide is still very severe. Presently, many breakthroughs have been accomplished in the research and development of drugs for the treatment of COVID-19, especially vaccines; however, some of the so-called COVID-19-specific drugs highli...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Fang, Yuan, Hao, Wu, Sixian, Zhou, Yifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673875/
https://www.ncbi.nlm.nih.gov/pubmed/34818922
http://dx.doi.org/10.1177/00469580211055630
_version_ 1784615535132016640
author Peng, Fang
Yuan, Hao
Wu, Sixian
Zhou, Yifeng
author_facet Peng, Fang
Yuan, Hao
Wu, Sixian
Zhou, Yifeng
author_sort Peng, Fang
collection PubMed
description The current situation of Coronavirus Disease 2019 (COVID-19) worldwide is still very severe. Presently, many breakthroughs have been accomplished in the research and development of drugs for the treatment of COVID-19, especially vaccines; however, some of the so-called COVID-19-specific drugs highlighted in the early stage failed to achieve the expected curative effect. There is no antiviral therapy available, by stimulating protective immunity vaccine is the best choice for the future management of infection. Therefore, we aimed to identify the latest developments in the research and development of these drugs and vaccines and provide a reference for the prevention and treatment of COVID-19.
format Online
Article
Text
id pubmed-8673875
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-86738752021-12-16 Recent Advances on Drugs and Vaccines for COVID-19 Peng, Fang Yuan, Hao Wu, Sixian Zhou, Yifeng Inquiry Original Research Article The current situation of Coronavirus Disease 2019 (COVID-19) worldwide is still very severe. Presently, many breakthroughs have been accomplished in the research and development of drugs for the treatment of COVID-19, especially vaccines; however, some of the so-called COVID-19-specific drugs highlighted in the early stage failed to achieve the expected curative effect. There is no antiviral therapy available, by stimulating protective immunity vaccine is the best choice for the future management of infection. Therefore, we aimed to identify the latest developments in the research and development of these drugs and vaccines and provide a reference for the prevention and treatment of COVID-19. SAGE Publications 2021-11-24 /pmc/articles/PMC8673875/ /pubmed/34818922 http://dx.doi.org/10.1177/00469580211055630 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Peng, Fang
Yuan, Hao
Wu, Sixian
Zhou, Yifeng
Recent Advances on Drugs and Vaccines for COVID-19
title Recent Advances on Drugs and Vaccines for COVID-19
title_full Recent Advances on Drugs and Vaccines for COVID-19
title_fullStr Recent Advances on Drugs and Vaccines for COVID-19
title_full_unstemmed Recent Advances on Drugs and Vaccines for COVID-19
title_short Recent Advances on Drugs and Vaccines for COVID-19
title_sort recent advances on drugs and vaccines for covid-19
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673875/
https://www.ncbi.nlm.nih.gov/pubmed/34818922
http://dx.doi.org/10.1177/00469580211055630
work_keys_str_mv AT pengfang recentadvancesondrugsandvaccinesforcovid19
AT yuanhao recentadvancesondrugsandvaccinesforcovid19
AT wusixian recentadvancesondrugsandvaccinesforcovid19
AT zhouyifeng recentadvancesondrugsandvaccinesforcovid19

Ejemplares similares